文献速递脑血管病

血管内卒中治疗中个体化与标准化血压管理对临床结局的影响:一项随机临床试验

Effect of Individualized Versus Standardized Blood Pressure Management During Endovascular Stroke Treatment on Clinical Outcome: A Randomized Clinical Trial.
PubMed 文献 · Stroke · 2023-09-21

INDIVIDUATE 研究为前瞻性随机开放盲终点(PROBE)设计,在单中心纳入 250 例前循环急性缺血性卒中且接受血管内治疗的患者,比较以术前基线收缩压为术中目标的个体化血压管理与维持术中收缩压 140–180 mm Hg 的标准化管理。结果显示两组 90 天良好功能结局比例无显著差异(25% vs 24%;校正 OR 0.81,95%CI 0.41–1.61;P=0.56)。

要点

  • 个体化组与标准化组术中平均收缩压相似(157 vs 154 mm Hg;P=0.16)。
  • 90 天良好功能结局(改良 Rankin 量表 0–2 分)个体化组 25% vs 标准化组 24%,无显著差异。
  • 校正 OR 0.81(95%CI 0.41–1.61;P=0.56),未达统计学显著。

核心结论

  • 在前循环急性缺血性卒中接受血管内治疗的患者中,以术中收缩压目标为基线值的个体化血压管理策略与维持收缩压 140–180 mm Hg 的标准化方案相比,未见显著差异。

研究设计与样本

  • INDIVIDUATE 研究为随机临床试验,采用前瞻性随机开放盲终点(PROBE)设计。
  • 2020年10月1日至2022年7月7日在单中心三级大学医院招募患者。
  • 纳入标准为前循环急性缺血性卒中、颈内动脉和大脑中动脉闭塞、美国国立卫生研究院卒中量表评分≥8 分且在程序性镇静下接受血管内治疗。
  • 共 250 例患者纳入分析,平均(SD)年龄 77(12)岁,女性 142 例(57%),入院时平均(SD)美国国立卫生研究院卒中量表评分 17(5.2)。
  • 个体化组 123 例(49%),标准化组 127 例(51%)。

主要发现

  • 术中平均(SD)收缩压个体化组 vs 标准化组为 157(19)vs 154(18)mm Hg;P=0.16。
  • 90 天良好功能结局(改良 Rankin 量表 0–2 分)个体化组 25% vs 标准化组 24%;校正 OR 0.81(95%CI 0.41–1.61);P=0.56。

关键数值与推荐

  • 个体化血压管理策略以术前基线收缩压值作为术中血压目标。
  • 标准化对照治疗目标为维持术中收缩压介于 140 和 180 mm Hg 之间。
  • 主要预设结局为卒中后 90 天良好功能结局比例,定义为改良 Rankin 量表评分 0 至 2 分。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Optimal blood pressure (BP) management during endovascular stroke treatment is not well established. We studied whether an individualized approach for managing BP during endovascular stroke treatment gives a better clinical outcome than an approach with standardized systolic BP targets. METHODS: The INDIVIDUATE study (Individualized Blood Pressure Management During Endovascular Treatment of Acute Ischemic Stroke Under Procedural Sedation) is a randomized clinical trial with a prospective randomized open blinded end point (PROBE) design. Patients were recruited between October 1, 2020 and July 7, 2022 at a single center at a tertiary care university hospital. Patients were eligible, when they were suffering from acute ischemic stroke of the anterior circulation with occlusions of the internal carotid artery and middle cerebral artery and a National Institutes of Health Stroke Scale score of ≥8 receiving endovascular stroke treatment in procedural sedation. The intervention consists of an individualized BP management strategy, where preinterventional baseline systolic BP (SBP) values are used as intraprocedural BP targets. As a control, the standard treatment aims to maintain the intraprocedural SBP between 140 and 180 mm Hg. The main prespecified outcome is the proportion of favorable functional outcomes 90 days after stroke, defined as a modified Rankin Scale score of 0 to 2. RESULTS: Two hundred fifty patients were enrolled and included in the analysis, mean (SD) age was 77 (12) years, 142 (57%) patients were women, and mean (SD) National Institutes of Health Stroke Scale score on admission was 17 (5.2). In all, 123 (49%) patients were treated with individualized and 127 (51%) with standard BP management. Mean (SD) intraprocedural SBP was similar in the individualized versus standard BP management group (157 [19] versus 154 [18] mm Hg; P=0.16). The rate of favorable functional outcome after 3 months was not significantly different between the individualized versus the standard BP management group (25% versus 24%; adjusted odds ratio, 0.81 [95% CI, 0.41-1.61]; P=0.56). CONCLUSIONS: Among patients treated with endovascular stroke treatment due to an acute ischemic stroke of the anterior circulation, no significant difference was seen between the individualized BP management strategy, where intraprocedural SBP was targeted to baseline values, and the standardized regimen of targeting SBP between 140 and 180 mm Hg. REGISTRATION: URL: https://www. CLINICALTRIALS: gov; Unique identifier: NCT04578288.

来源:Stroke,查看原文。版权归原作者所有。

引用

  1. Chen M, Meis J, Potreck A, et al. Effect of Individualized Versus Standardized Blood Pressure Management During Endovascular Stroke Treatment on Clinical Outcome: A Randomized Clinical Trial. Stroke. 2023. PMID: 37732489. doi:10.1161/STROKEAHA.123.044062

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。